FDA Inspection
Apotex, Inc. BioClinical Development Clinical Operations DepartmentApotex, Inc. BioClinical Development Clinical Operations Department – FDA Inspection, Jan 13, 2017
Record Details
This FDA Inspection record concerns Apotex, Inc. BioClinical Development Clinical Operations Department, with an inspection on January 13, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- January 13, 2017
- Product Type
- Human Drugs
View Company Profile
ID · 081dfea0-ae7f-4e63-9c3a-5a3908c323c7
Inspection Facts
- Inspection number
- 1002932
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Apotex, Inc. BioClinical Development Clinical Operations Department
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Apotex, Inc. BioClinical Development Clinical Operations Department
- FDA Inspection 1005519 - 2017-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.